1. Against the new H1N1 influenza (swine influenza): Vaccinate or don’t vaccinate (all)? That is currently the question!

   • H. W. Doerr
   • R. Allwinn
   • J. Cinatl

   Editorial 18 September 2009 Pages: 379 - 380

2. An influenza A H1N1 virus revival – pandemic H1N1/09 virus

   • M. Michaelis
   • H. W. Doerr
   • J. Cinatl Jr

   Review 18 September 2009 Pages: 381 - 389

3. Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

   • P. R. Blank
   • M. Schwenkglenks
   • T. D. Szucs

   Clinical and Epidemiological Study 18 September 2009 Pages: 390 - 400

4. Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008

   • E. Terletskaia-Ladwig
   • M. Eggers
   • M. Enders

   Clinical and Epidemiological Study 07 August 2009 Pages: 401 - 406

5. Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections

   • R. Vick-Fragoso
   • G. Hernández-Oliva
   • The STIC Study Group

   Clinical and Epidemiological Study 18 September 2009 Pages: 407 - 417

6. Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis

   • J. Riethmueller
   • S. Junge
   • M. Stern

   Clinical and Epidemiological Study 05 September 2009 Pages: 418 - 423

7. Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

   • J. Riethmueller
   • M. Ballmann
   • German Multicenter Study Group

   Clinical and Epidemiological Study 05 September 2009 Pages: 424 - 431

8. Correlation between antibiotic use and resistance in a hospital: Temporary and ward-specific observations

   • I. Willemsen
   • D. Bogaers-Hofman
   • J. Kluytmans

   Clinical and Epidemiological Study 04 June 2009 Pages: 432 - 437

9. Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: Predictors of virological response and drug resistance evolution in a multi-cohort study

   • S. Di Giambenedetto
   • C. Torti
   • UCSC cohort, MASTER cohort and ARCA cohort

   Clinical and Epidemiological Study 07 August 2009 Pages: 438 - 444

10. Occult hepatitis B virus infection in a Cohort of HIV-positive patients: Correlation with hepatitis C virus coinfection, virological and immunological features

    • G. Morsica
    • F. Ancarani
    • HepaICONA and the ICONA Study Groups

    Brief Report 07 August 2009 Pages: 445 - 449

11. Immuno-detection of Staphylococcus aureus biofilm on a cochlear implant

    • M. I. Kos
    • L. Stenz
    • J. Schrenzel

    Brief Report 10 March 2009 Pages: 450 - 454

12. Surgical site infections in HIV-infected patients: Results from an Italian prospective multicenter observational study

    • C. M. J. Drapeau
    • A. Pan
    • N. Petrosillo

    Brief Report 02 September 2009 Pages: 455 - 460

13. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections

    • M. Montero
    • J. P. Horcajada
    • H. Knobel

    Brief Report 04 June 2009 Pages: 461 - 465

14. Cutaneous vasculitis associated with fluoroquinolones

    • G. Maunz
    • T. Conzett
    • W. Zimmerli

    Case Report 07 August 2009 Pages: 466 - 468

15. Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease

    • T. Shigemura
    • K. Agematsu
    • K. Koike

    Case Report 07 August 2009 Pages: 469 - 473

16. Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: Dissemination in Southern Brazil

    • A. F. Martins
    • R. Kuchenbecker
    • A. L. Barth

    Correspondence 18 September 2009 Pages: 474 - 476